INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
SK
Shepard Alan KDirector, President & CEO
CNXCNX Resources Corp
Option exercise
M—
39.8K sh
Aug 13, 2026Aug 17, 2026
Page 497 of 1689
← PrevNext →
traded Aug 13, 2026
+4d
SEC Form 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$17K
4,575 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
4,541 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
MJ
Muguiro Dominguez JaimeChief Executive Officer
CXCEMEX SAB DE CV
Grant or award
A—
382.1K sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Tax withholding
F$2,380
638 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
MF
Miller Michael FrancisChief Technology Officer
QTRXQuanterix Corp
Option exercise
M—
135 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
MF
Miller Michael FrancisChief Technology Officer
QTRXQuanterix Corp
Option exercise
M—
81 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
6,392 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
MM
Menendez Sergio MauricioPresident of Cemex Mexico
CXCEMEX SAB DE CV
Grant or award
A—
372.6K sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$11K
2,817 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
2,636 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$10K
2,803 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
BN
Behl NavneetChief Operating Officer
CNXCNX Resources Corp
Option exercise
M—
39.8K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
1,686 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
MF
Miller Michael FrancisChief Technology Officer
QTRXQuanterix Corp
Option exercise
M—
136 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
NR
Naya Barba RicardoEVP Sust., Ops. & Ventures
CXCEMEX SAB DE CV
Grant or award
A—
382.7K sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

13
FW
Forsythe WendyChief Marketing Officer
AGNTAGNT, Inc.
Tax withholding
F$2,675
615 sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

13
KS
Kereere SuzanPresident, Global Markets
PYPLPayPal Holdings, Inc.
Option exercise
M—
8,503 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
SK
Shepard Alan KDirector, President & CEO
CNXCNX Resources Corp
Option exercise
M—
39.8K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Tax withholding
F$3,200
858 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

13
OO
Offer OrChief Executive Officer
SMWBSIMILARWEB LTD.
Option exercise
M—
200.0K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

12
TR
Thompson Patrick RyanSee Remarks
MAXMediaAlpha, Inc.
Tax withholding
F$82K
6,252 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

12
PK
Papenfuss Donnalee KathleenEVP-Strategy and Communication
FASTFASTENAL CO
Option exercise
M$150K
7,894 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

12
AG
Albo GiuseppinaDirector, Chief Executive Officer
HGHamilton Insurance Group, Ltd.
Gift
G—
100.4K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

12
TR
Thompson Patrick RyanSee Remarks
MAXMediaAlpha, Inc.
Tax withholding
F$58K
4,366 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

12
TR
Thompson Patrick RyanSee Remarks
MAXMediaAlpha, Inc.
Tax withholding
F$69K
5,258 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

12
TR
Thompson Patrick RyanSee Remarks
MAXMediaAlpha, Inc.
Tax withholding
F$110K
8,333 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

12
WM
Weidner MarissaChief Corp. Resp. Officer
WBSWEBSTER FINANCIAL CORP
Tax withholding
F$124K
1,570 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

12
AG
Albo GiuseppinaDirector, Chief Executive Officer
HGHamilton Insurance Group, Ltd.
Gift
G—
100.4K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$167K
1,800 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$238K
2,600 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
LG
Liu GeneChief Accounting Officer
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$80K
492 sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

11
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$98K
1,100 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
OO
Offer OrChief Executive Officer
SMWBSIMILARWEB LTD.
Option exercise
M$695K
228.5K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
BO
Blachier OlivierPresident, Materials Solutions
ENTGENTEGRIS INC
Option exercise · 10b5-1 plan
M—
2,000 sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

11
LG
Liu GeneChief Accounting Officer
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$122K
737 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
YA
Yeh Kuanling AmyChief Technology Officer
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$163K
12.0K sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

11
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$165K
1,900 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

10
FJ
Friedl-Naderer JohannaChief Commercial Officer
DYNDyne Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$5,939
226 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

10
KD
Kerr DouglasChief Medical Officer
DYNDyne Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
1,556 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence